Anzeige
Mehr »
Dienstag, 01.07.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
248 Leser
Artikel bewerten:
(1)

Healthcare Patent Filing Outsourcing Market Size Worth $1.8 Billion By 2028: Grand View Research, Inc.

SAN FRANCISCO, March 22, 2021 /PRNewswire/ -- The global healthcare patent filing outsourcing market size is expected to reach USD 1.8 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected toexpand at a CAGR of 5.5% from 2021 to 2028. In-house departments of pharmaceutical and medical devices firms typically do not have sufficient time to carry out patent filing processes. Even if they do, it will be a costly option for the firms. Therefore, the market is significantly driven by the growing need for cost-saving and time-saving in patent filing processes.

Grand_View_Research_Logo

Key suggestions from the report:

  • Medtech accounted for the largest revenue share of 51.2% in 2020 owing to growing technological innovations in medical devices
  • Filing and prosecution services accounted for the largest revenue share of over 50.0% in 2020 owing to complexity, cost-efficiency, and time-saving associated with outsourcing such activities
  • By origin, non-resident is the fastest growing segment with a CAGR of 5.9% between 2021 to 2028 as national patent in one country might not prevent copying of a product or technology in a different country
  • Asia pacific region contributed for the largest share of 65.5% owing to high number of patents filed in the region coupled with availability of low cost outsourcing services in the region. Furthermore, the off-shore model is highly adopted in this industry, where such offices are majorly placed in countries such as India, Japan, Korea, Malaysia, Singapore and others

Read 120 page research report with ToC on "Healthcare Patent Filing Outsourcing Market Size, Share & Trends Analysis Report By Domain, By Service (Pre-filing, Filing & Prosecution, Post Grant), By Origin (Resident, Non-resident), By Region, And Segment Forecasts, 2021 - 2028" at:https://www.grandviewresearch.com/industry-analysis/healthcare-patent-filing-outsourcing-market

The market suffered a hefty decline of 2.1% in 2020 owing to the COVID-19 pandemic. Organizations such as the European Patent Office (EPO) and the United State Patent and Trademark Office (USPTO) announced relaxations such as extension of deadlines in order to accommodate 2019 novel coronavirus related delays and interruptions. However, with the lifting of COVID-19 related shelter-in-place mandates and commercialization of the vaccine, the bottle necking of patent filing is clearing. The market is projected to recover from 2021 onwards and expand with a lucrative CAGR over the forecast period.

Growing innovations in the medical device and pharmaceutical space is driving the market. Surging number of start-ups in the healthcare industry with new and innovative products, will also boost market growth. Patent applications are majorly filed by the well-established players in the healthcare industry such as Novartis, Covidien, Boston Scientific, Medtronic, Ethicon, Olympus Corp. These companies innovate in-house, partner with high-tech companies for consumer-facing offerings, and also license technologies from universities. Such companies hold huge potential market growth across the globe.

Grand View Research has segmented the global healthcare patent filing outsourcing market on the basis of domain, service, origin, and region:

  • Healthcare Patent Filing Outsourcing Domain Outlook (Revenue, USD Million, 2016 - 2028)
    • Medtech
      • Assistive Care devices
      • Consumables and Disposables
      • Diagnosis and Imaging Devices
      • Drug Delivery Devices
      • Surgical Devices
      • Wearable Medical Devices
    • Pharmaceutical
  • Healthcare Patent Filing Outsourcing Service Outlook (Revenue, USD Million, 2016 - 2028)
    • Pre-filing
    • Filing & Prosecution
    • Post Grant
  • Healthcare Patent Filing Outsourcing Origin Outlook (Revenue, USD Million, 2016 - 2028)
    • Resident
    • Non-resident
  • Healthcare Patent Filing Outsourcing Regional Outlook (Revenue, USD Million, 2016 - 2028)
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • France
      • U.K.
      • Spain
      • Italy
    • Asia Pacific
      • China
      • Japan
      • India
    • Latin America
      • Brazil
      • Mexico
      • Argentina
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE

List of Key Players of Healthcare Patent Filing Outsourcing Market

  • Clarivate
  • ipMetrix Consulting Group
  • CRJ IPR Services LLP
  • Patent Outsourcing Limited
  • Synoptic Intellectual Patents (P) Limited
  • Dennemeyer
  • Powell Gilbert
  • Bristows
  • Hoyng Rokh Monegier
  • Carpmaels & Ransford Services Limited

Find more research reports onMedical Devices Industry, by Grand View Research:

  • Drug Delivery Devices Market - The global drug delivery devices market size is expected to reach USD 345.8 billion by 2027. Increasing adoption of advanced technology for effectively delivering the drug on the target site is expected to drive the overall market growth.
  • Blood Glucose Monitoring Devices Market - The global blood glucose monitoring devices market size is expected to reach 19.6 billion by 2028. It is expected to expand at a CAGR of 7.6% from 2021 to 2028.
  • Neurothrombectomy Devices Market - The global neurothrombectomy devices market size is anticipated to reach USD 1.0 billion by 2028. The market is expected to expand at a CAGR of 6.5% from 2021 to 2028.

Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com
Follow Us: LinkedIn | Twitter

Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg

© 2021 PR Newswire
Die USA haben fertig! 5 Aktien für den China-Boom
Die Finanzwelt ist im Umbruch! Nach Jahren der Dominanz erschüttert Donald Trumps erratische Wirtschaftspolitik das Fundament des amerikanischen Kapitalismus. Handelskriege, Rekordzölle und politische Isolation haben eine Kapitalflucht historischen Ausmaßes ausgelöst.

Milliarden strömen aus den USA – und suchen neue, lukrative Ziele. Und genau hier kommt China ins Spiel. Trotz aller Spannungen wächst die chinesische Wirtschaft dynamisch weiter, Innovation und Digitalisierung treiben die Märkte an.

Im kostenlosen Spezialreport stellen wir Ihnen 5 Aktien aus China vor, die vom US-Niedergang profitieren und das Potenzial haben, den Markt regelrecht zu überflügeln. Wer jetzt klug investiert, sichert sich den Zugang zu den neuen Wachstums-Champions von morgen.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche 5 Aktien die Konkurrenz aus den USA outperformen dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.